Urinary Soluble Urokinase Receptor Levels Are Elevated and Pathogenic in Patients With Primary Focal Segmental Glomerulosclerosis

BMC Medicine - United Kingdom
doi 10.1186/1741-7015-12-81
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Urinary Prognostic Biomarkers in Patients With Focal Segmental Glomerulosclerosis

Nephro-Urology Monthly
Urology
2014English

Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Focal Segmental Glomerulosclerosis; A Retrospective Analysis

Journal of Nephropathology
Nephrology
2018English

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Are Elevated in Severe Pre-Eclampsia

Journal of Clinical Gynecology and Obstetrics
2016English

Primary Focal Segmental Glomerulosclerosis: miRNAs and Targeted Therapies

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2016English

Focal Segmental Glomerulosclerosis

American Journal of Medicine
Medicine
1974English

NPHS2variation in Focal and Segmental Glomerulosclerosis

BMC Nephrology
Nephrology
2008English

Genetics of Focal Segmental Glomerulosclerosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2007English

Focal Segmental Glomerulosclerosis and Multiple Myeloma.

International Journal of Advanced Research
2018English

The Pathogenesis of Focal Segmental Glomerulosclerosis

Advances in Chronic Kidney Disease
Nephrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy